Report
Our reports provide latest industry trends, forecasts, company profiles, competitive landscape, and strategic insights.
Stem Cell Therapy Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Adult Stem Cell Therapy, Embryonic Stem Cell Therapy, Induced Pluripotent Stem Cell Therapy, and Other Stem Cell Therapy), Treatment (Allogeneic and Autologous), Application (Musculoskeletal, Dermatology, Cardiology, Drug Discovery & Development, and Other Applications), and End User (Hospitals & Specialty Clinics and Academic & Research Institutes), and Geography
- Report Code : TIPHE100000991
- Pages : 206
The stem cell therapy market size is expected to grow from US$ 2,278.49 million in 2022 to US$ 6,206.89 million by 2028. The market is estimated to register a CAGR of 18.2% from 2022 to 2028.
The growth of the global stem cell therapy market is majorly driven by increasing research activities related to stem cell therapy for effective disease management, and growing prevalence of cancer. However, the availability of illegal and unapproved products, and the high cost of approved treatments hamper the market growth.
Stem cells are preliminary body cells from which all other cells with specialized functions are generated. Under a controlled environment in the body or a clinical laboratory, these cells divide to form more cells, called daughter cells. With the advent of modern health science, these cells have been demonstrated to play a major role in understanding the occurrence of diseases, the generation of advanced regenerative medicines, and the discovery of other drugs. Stem cells are formed in embryos, bone marrow, body fats, and umbilical cord blood, among others.
The US is investing massive resources in its healthcare sector for accelerating research and development activities in stem cell technologies. These activities are projected to drive organic developments such as product launches, product approvals, and new product innovations. Financial aid from investors, government authorities, and significant players is, thus, likely to favor the stem cell therapy market growth in the US. In July 2019, Century Therapeutics raised US$ 250 million through a financing round to develop induced pluripotent stem cells (iPSC), which will be utilized in an allogeneic cell therapy platform. Moreover, in December 2019, NIH launched the US’s first clinical study of patient-derived stem cell therapy for the treatment of the retina. Such studies, combined with developments in regenerative medicine, are expected to drive the acceptance and adoption of stem cell therapy in the US, which, in turn, will drive the market by 2027. For instance, in May 2019, SpinalCyte, LLC, a clinical-stage regenerative medicine company, announced the launch of a new comprehensive platform to raise awareness of the potential benefits served by fibroblasts and their promising applications in regenerative medicine technology.
The COVID-19 pandemic disrupted people’s lives and business operations worldwide. The COVID-19 pandemic had a positive impact on the stem cell therapy market. The application of stem cells in the treatment of COVID-19 infection has gathered the attention of medical researchers, resulting in a higher number of clinical trials. Regenerative medicine based on cellular therapies may be developed as a treatment option for patients, lowering infection rates and mortality. Research institutes and companies are collaborating to develop novel treatment options for the disease. For instance, in April 2020, Infectious Disease Research Institute and Celularity announced that the US FDA had approved a clinical trial application to develop cell-based therapy for COVID-19. Thus, researchers are increasingly attempting to develop stem cell therapies targeting COVID-19. In January 2020, researchers from the University of Miami administered two stem cell infusions to COVID-19 patients suffering from lung damage. The results concluded that there were no significant side effects, and the therapy was reliable. Thus, increasing demand for regenerative medicines has had a positive effect on the stem cell therapy market during the COVID-19 pandemic.
The stem cell therapy market in Canada is expected to grow in the future owing to the development of the healthcare sector and rapidly increasing investments in stem cell therapy technology. On the other hand, in Mexico, increasing awareness of the benefits offered by stem cell therapy would benefit the stem cell therapy market.
In 2020, Australia, Japan, Korea, and New Zealand took better measures than other Asia Pacific countries to flatten the curve of SARS-CoV-2 infection. They developed effective testing, tracing, and isolation systems to ensure that people comply with social distancing and similar key guidelines. Other countries, including Vietnam and Thailand, demonstrated the value of a proactive response to contain the virus and limit deaths. However, the onset of the COVID-19 crisis severely affected cancer, heart disease, diabetes, HIV, tuberculosis, and malaria prevention and treatment services in Asia Pacific. The number of COVID-19 cases in India has dropped significantly compared to trends recorded in 2020 and 2021. The repercussions of the pandemic, including supply chain disruptions owing to extended factory shutdowns and production delays, persisted for a short period. However, as the demand exceeded supply, the country experienced a hike in commodity prices.
In a new research methodology for developing a treatment for COVID-19, stem cell therapy and stem-cell-derived organoid models have received high attention. Additionally, clinical studies reveal that various organoids derived from stem cells act as an ideal model to explore the possibility and mechanism of SARS-CoV-2 infecting multiple organs, and the outcomes can better research for clinical treatment. Moreover, stem cell therapy was made available for severe COVID-19 patients and for people recovered from severe complications to facilitate the repair of damaged lungs.
Application-Based Insights
Based on application, the stem cell therapy market is divided into musculoskeletal, dermatology, cardiology, drug discovery and development, and other applications. The drug discovery and development segment held the largest share of the market in 2021 and is expected to register the highest CAGR during the forecast period.
End User-Based Insights
Based on end user, the stem cell therapy market is segmented into academic & research institutes and hospitals & clinics. The academic & research institutes segment held a larger share of the market in 2021, and the same segment is expected to register a higher CAGR during the forecast period (2022–2028).
A few of the major primary and secondary sources referred to while preparing the report on the stem cell therapy market are the World Health Organization (WHO), the US Census Bureau, and the US National Library of Medicine.
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Stem Cell Therapy Market – By Type
1.3.2 Global Stem Cell Therapy Market – By Treatment
1.3.3 Global Stem Cell Therapy Market – By Application
1.3.4 Global Stem Cell Therapy Market – By End User
1.3.5 Global Stem Cell Therapy Market – By Geography
2. Stem Cell Therapy Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Stem Cell Therapy Market– Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America PEST Analysis
4.2.2 Europe – PEST Analysis
4.2.3 Asia Pacific – PEST Analysis
4.2.4 South and Central America (SCAM) – PEST Analysis
4.2.5 Middle East and Africa PEST Analysis
4.3 Experts Opinion
5. Stem Cell Therapy Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Research Activities Related to Stem Cell Therapy for Effective Disease Management
5.1.2 Growing Prevalence of Cancer
5.2 Market Restraints
5.2.1 Availability of Illegal and Unapproved Products, and High Cost of Approved Treatments
5.3 Market Opportunities
5.3.1 Use of Induced Pluripotent Stem Cells in Regenerative Medicines
5.4 Future Trends
5.4.1 Research Activities and Product Innovations
5.5 Impact Analysis
6. Stem Cell Therapy Market – Global Analysis
6.1 Global Stem Cell Therapy Market Revenue Forecast and Analysis
6.2 Global Stem Cell Therapy Market, By Geography – Forecast and Analysis
6.3 Market Positioning of Key Players
7. Global Stem Cell Therapy Market – Revenue and Forecast to 2028 – by Type
7.1 Overview
7.2 Stem Cell Therapy Market Revenue Share, by Type 2021 & 2028 (%)
7.3 Adult Stem Cell Therapy
7.3.1 Overview
7.3.2 Adult Stem Cell Therapy: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
7.3.3 Hematopoietic Stem Cell Therapy
7.3.3.1 Overview
7.3.3.2 Hematopoietic Stem Cell Therapy: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
7.3.4 Umbilical Cord Stem Cell Therapy
7.3.4.1 Overview
7.3.4.2 Umbilical Cord Stem Cell Therapy: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
7.3.5 Neuronal Stem Cell Therapy
7.3.5.1 Overview
7.3.5.2 Neuronal Stem Cell Therapy: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
7.3.6 Mesenchymal Stem Cell
7.3.6.1 Overview
7.3.6.2 Mesenchymal Stem Cell: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Embryonic Stem Cell Therapy
7.4.1 Overview
7.4.2 Embryonic Stem Cell Therapy: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
7.5 Induced Pluripotent Stem Cell Therapy
7.5.1 Overview
7.5.2 Induced Pluripotent Stem Cell Therapy: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
7.6 Other Stem Cell Therapy
7.6.1 Overview
7.6.2 Other Stem Cell Therapy: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
8. Global Stem Cell Therapy Market Analysis and Forecasts to 2028 – by Treatment
8.1 Overview
8.2 Global Stem Cell Therapy Market, by Treatment 2021 & 2028 (%)
8.3 Allogeneic
8.3.1 Overview
8.3.2 Allogeneic: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Autologous
8.4.1 Overview
8.4.2 Autologous: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
9. Global Stem Cell Therapy Market Analysis and Forecasts to 2028 – by Application
9.1 Overview
9.2 Global Stem Cell Therapy Market, by Application 2021 & 2028 (%)
9.3 Musculoskeletal
9.3.1 Overview
9.3.2 Musculoskeletal: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Dermatology
9.4.1 Overview
9.4.2 Dermatology: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Cardiology
9.5.1 Overview
9.5.2 Cardiology: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
9.6 Drug Discovery and Development
9.6.1 Overview
9.6.2 Drug Discovery and Development: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
9.7 Other Applications
9.7.1 Overview
9.7.2 Other Applications: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
10. Global Stem Cell Therapy Market – Revenue and Forecast to 2028 – by End User
10.1 Overview
10.2 Stem Cell Therapy Market Revenue Share, by End User 2021 & 2028 (%)
10.3 Academic & Research Institutes
10.3.1 Overview
10.3.2 Academic & Research Institutes: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
10.4 Hospitals & Specialty Clinics
10.4.1 Overview
10.4.2 Hospitals & Specialty Clinics: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
11. Stem Cell Therapy Market – Revenue and Forecast to 2028 – Geographic Analysis
11.1 North America: Stem Cell Therapy Market
11.1.1 Overview
11.1.2 North America: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
11.1.3 North America: Stem Cell Therapy Market, by Type, 2019–2028 (US$ Million)
11.1.3.1 North America: Stem Cell Therapy Market, by Adult Stem Cell Therapy, 2019–2028 (US$ Million)
11.1.4 North America: Stem Cell Therapy Market, by Treatment, 2019–2028 (US$ Million)
11.1.5 North America: Stem Cell Therapy Market, by Application, 2019–2028 (US$ Million)
11.1.6 North America: Stem Cell Therapy Market, by End User, 2019–2028 (US$ Million)
11.1.6.1 US: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
11.1.6.1.1 Overview
11.1.6.1.2 US: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
11.1.6.1.3 US: Stem Cell Therapy Market, by Type, 2019–2028 (US$ Million)
11.1.6.1.3.1 US: Stem Cell Therapy Market, by Adult Stem Cell Therapy, 2019–2028 (US$ Million)
11.1.6.1.4 US: Stem Cell Therapy Market, by Treatment, 2019–2028 (US$ Million)
11.1.6.1.5 US: Stem Cell Therapy Market, by Application, 2019–2028 (US$ Million)
11.1.6.1.6 US: Stem Cell Therapy Market, by End User, 2019–2028 (US$ Million)
11.1.6.2 Canada: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
11.1.6.2.1 Overview
11.1.6.2.2 Canada: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
11.1.6.2.3 Canada: Stem Cell Therapy Market, by Type, 2019–2028 (US$ Million)
11.1.6.2.3.1 Canada: Stem Cell Therapy Market, by Adult Stem Cell Therapy, 2019–2028 (US$ Million)
11.1.6.2.4 Canada: Stem Cell Therapy Market, by Treatment, 2019–2028 (US$ Million)
11.1.6.2.5 Canada: Stem Cell Therapy Market, by Application, 2019–2028 (US$ Million)
11.1.6.2.6 Canada: Stem Cell Therapy Market, by End User, 2019–2028 (US$ Million)
11.1.6.3 Mexico: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
11.1.6.3.1 Overview
11.1.6.3.2 Mexico: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
11.1.6.3.3 Mexico: Stem Cell Therapy Market, by Type, 2019–2028 (US$ Million)
11.1.6.3.3.1 Mexico: Stem Cell Therapy Market, by Adult Stem Cell Therapy, 2019–2028 (US$ Million)
11.1.6.3.4 Mexico: Stem Cell Therapy Market, by Treatment, 2019–2028 (US$ Million)
11.1.6.3.5 Mexico: Stem Cell Therapy Market, by Application, 2019–2028 (US$ Million)
11.1.6.3.6 Mexico: Stem Cell Therapy Market, by End User, 2019–2028 (US$ Million)
11.2 Europe: Stem Cell Therapy Market
11.2.1 Overview
11.2.2 Europe: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
11.2.3 Europe: Stem Cell Therapy Market, by Type, 2019–2028 (US$ Million)
11.2.3.1 Europe: Stem Cell Therapy Market, by Adult Stem Cell Therapy, 2019–2028 (US$ Million)
11.2.4 Europe: Stem Cell Therapy Market, by Treatment, 2019–2028 (US$ Million)
11.2.5 Europe: Stem Cell Therapy Market, by Application, 2019–2028 (US$ Million)
11.2.6 Europe: Stem Cell Therapy Market, by End User, 2019–2028 (US$ Million)
11.2.7 Europe: Stem Cell Therapy Market, by Country, 2021 & 2028 (%)
11.2.7.1 Germany: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
11.2.7.1.1 Overview
11.2.7.1.2 Germany: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
11.2.7.1.3 Germany: Stem Cell Therapy Market, by Type, 2019–2028 (US$ Million)
11.2.7.1.3.1 Germany: Stem Cell Therapy Market, by Adult Stem Cell Therapy, 2019–2028 (US$ Million)
11.2.7.1.4 Germany: Stem Cell Therapy Market, by Treatment, 2019–2028 (US$ Million)
11.2.7.1.5 Germany: Stem Cell Therapy Market, by Application, 2019–2028 (US$ Million)
11.2.7.1.6 Germany: Stem Cell Therapy Market, by End User, 2019–2028 (US$ Million)
11.2.7.2 UK: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
11.2.7.2.1 Overview
11.2.7.2.2 UK: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
11.2.7.2.3 UK: Stem Cell Therapy Market, by Type, 2019–2028 (US$ Million)
11.2.7.2.3.1 UK: Stem Cell Therapy Market, by Adult Stem Cell Therapy, 2019–2028 (US$ Million)
11.2.7.2.4 UK: Stem Cell Therapy Market, by Treatment, 2019–2028 (US$ Million)
11.2.7.2.5 UK: Stem Cell Therapy Market, by Application, 2019–2028 (US$ Million)
11.2.7.2.6 UK: Stem Cell Therapy Market, by End User, 2019–2028 (US$ Million)
11.2.7.3 France: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
11.2.7.3.1 Overview
11.2.7.3.2 France: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
11.2.7.3.3 France: Stem Cell Therapy Market, by Type, 2019–2028 (US$ Million)
11.2.7.3.3.1 France: Stem Cell Therapy Market, by Adult Stem Cell Therapy, 2019–2028 (US$ Million)
11.2.7.3.4 France: Stem Cell Therapy Market, by Treatment, 2019–2028 (US$ Million)
11.2.7.3.5 France: Stem Cell Therapy Market, by Application, 2019–2028 (US$ Million)
11.2.7.3.6 France: Stem Cell Therapy Market, by End User, 2019–2028 (US$ Million)
11.2.7.4 Italy: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
11.2.7.4.1 Overview
11.2.7.4.2 Italy: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
11.2.7.4.3 Italy: Stem Cell Therapy Market, by Type, 2019–2028 (US$ Million)
11.2.7.4.3.1 Italy: Stem Cell Therapy Market, by Adult Stem Cell Therapy, 2019–2028 (US$ Million)
11.2.7.4.4 Italy: Stem Cell Therapy Market, by Treatment, 2019–2028 (US$ Million)
11.2.7.4.5 Italy: Stem Cell Therapy Market, by Application, 2019–2028 (US$ Million)
11.2.7.4.6 Italy: Stem Cell Therapy Market, by End User, 2019–2028 (US$ Million)
11.2.7.5 Spain: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
11.2.7.5.1 Overview
11.2.7.5.2 Spain: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
11.2.7.5.3 Spain: Stem Cell Therapy Market, by Type, 2019–2028 (US$ Million)
11.2.7.5.3.1 Spain: Stem Cell Therapy Market, by Adult Stem Cell Therapy, 2019–2028 (US$ Million)
11.2.7.5.4 Spain: Stem Cell Therapy Market, by Treatment, 2019–2028 (US$ Million)
11.2.7.5.5 Spain: Stem Cell Therapy Market, by Application, 2019–2028 (US$ Million)
11.2.7.5.6 Spain: Stem Cell Therapy Market, by End User, 2019–2028 (US$ Million)
11.2.7.6 Rest of Europe: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
11.2.7.6.1 Overview
11.2.7.6.2 Rest of Europe: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
11.2.7.6.3 Rest of Europe: Stem Cell Therapy Market, by Type, 2019–2028 (US$ Million)
11.2.7.6.3.1 Rest of Europe: Stem Cell Therapy Market, by Adult Stem Cell Therapy, 2019–2028 (US$ Million)
11.2.7.6.4 Rest of Europe: Stem Cell Therapy Market, by Treatment, 2019–2028 (US$ Million)
11.2.7.6.5 Rest of Europe: Stem Cell Therapy Market, by Application, 2019–2028 (US$ Million)
11.2.7.6.6 Rest of Europe: Stem Cell Therapy Market, by End User, 2019–2028 (US$ Million)
11.3 Asia Pacific: Stem Cell Therapy Market
11.3.1 Overview
11.3.2 Asia Pacific: Stem Cell Therapy Market – Revenue and Forecast to 2028 (USD Million)
11.3.3 Asia Pacific: Stem Cell Therapy Market, by Type, 2019-2028 (USD Million)
11.3.3.1 Asia Pacific: Stem Cell Therapy Market, by Adult Stem Cell Therapy, 2019-2028 (USD Million)
11.3.4 Asia Pacific: Stem Cell Therapy Market, by Treatment, 2019-2028 (USD Million)
11.3.5 Asia Pacific: Stem Cell Therapy Market, by Application, 2019-2028 (USD Million)
11.3.6 Asia Pacific: Stem Cell Therapy Market, by End User , 2019-2028 (USD Million)
11.3.7 Asia Pacific: Stem Cell Therapy Market, by Country, 2021 & 2028 (%)
11.3.7.1 China: Stem Cell Therapy Market – Revenue and Forecast to 2028 (USD Million)
11.3.7.1.1 China: Stem Cell Therapy Market – Revenue and Forecast to 2028 (USD Million)
11.3.7.1.2 China: Stem Cell Therapy Market, by Type, 2019-2028 (USD Million)
11.3.7.1.2.1 China: Stem Cell Therapy Market, by Adult Stem Cell Therapy, 2019-2028 (USD Million)
11.3.7.1.3 China: Stem Cell Therapy Market, by Treatment, 2019-2028 (USD Million)
11.3.7.1.4 China: Stem Cell Therapy Market, by Application, 2019-2028 (USD Million)
11.3.7.1.5 China: Stem Cell Therapy Market, by End User , 2019-2028 (USD Million)
11.3.7.2 Japan: Stem Cell Therapy Market – Revenue and Forecast to 2028 (USD Million)
11.3.7.2.1 Japan: Stem Cell Therapy Market – Revenue and Forecast to 2028 (USD Million)
11.3.7.2.2 Japan: Stem Cell Therapy Market, by Type, 2019-2028 (USD Million)
11.3.7.2.2.1 Japan: Stem Cell Therapy Market, by Adult Stem Cell Therapy, 2019-2028 (USD Million)
11.3.7.2.3 Japan: Stem Cell Therapy Market, by Treatment, 2019-2028 (USD Million)
11.3.7.2.4 Japan: Stem Cell Therapy Market, by Application, 2019-2028 (USD Million)
11.3.7.2.5 Japan: Stem Cell Therapy Market, by End User , 2019-2028 (USD Million)
11.3.7.3 India: Stem Cell Therapy Market – Revenue and Forecast to 2028 (USD Million)
11.3.7.3.1 India: Stem Cell Therapy Market – Revenue and Forecast to 2028 (USD Million)
11.3.7.3.2 India: Stem Cell Therapy Market, by Type, 2019-2028 (USD Million)
11.3.7.3.2.1 India: Stem Cell Therapy Market, by Adult Stem Cell Therapy, 2019-2028 (USD Million)
11.3.7.3.3 India: Stem Cell Therapy Market, by Treatment, 2019-2028 (USD Million)
11.3.7.3.4 India: Stem Cell Therapy Market, by Application, 2019-2028 (USD Million)
11.3.7.3.5 India: Stem Cell Therapy Market, by End User , 2019-2028 (USD Million)
11.3.7.4 South Korea: Stem Cell Therapy Market – Revenue and Forecast to 2028 (USD Million)
11.3.7.4.1 South Korea: Stem Cell Therapy Market – Revenue and Forecast to 2028 (USD Million)
11.3.7.4.2 South Korea: Stem Cell Therapy Market, by Type, 2019-2028 (USD Million)
11.3.7.4.2.1 South Korea: Stem Cell Therapy Market, by Adult Stem Cell Therapy, 2019-2028 (USD Million)
11.3.7.4.3 South Korea: Stem Cell Therapy Market, by Treatment, 2019-2028 (USD Million)
11.3.7.4.4 South Korea: Stem Cell Therapy Market, by Application, 2019-2028 (USD Million)
11.3.7.4.5 South Korea: Stem Cell Therapy Market, by End User , 2019-2028 (USD Million)
11.3.7.5 Australia: Stem Cell Therapy Market – Revenue and Forecast to 2028 (USD Million)
11.3.7.5.1 Australia: Stem Cell Therapy Market – Revenue and Forecast to 2028 (USD Million)
11.3.7.5.2 Australia: Stem Cell Therapy Market, by Type, 2019-2028 (USD Million)
11.3.7.5.2.1 Australia: Stem Cell Therapy Market, by Adult Stem Cell Therapy, 2019-2028 (USD Million)
11.3.7.5.3 Australia: Stem Cell Therapy Market, by Treatment, 2019-2028 (USD Million)
11.3.7.5.4 Australia: Stem Cell Therapy Market, by Application, 2019-2028 (USD Million)
11.3.7.5.5 Australia: Stem Cell Therapy Market, by End User, 2019-2028 (USD Million)
11.3.7.6 Rest of Asia Pacific: Stem Cell Therapy Market – Revenue and Forecast to 2028 (USD Million)
11.3.7.6.1 Rest of Asia Pacific: Stem Cell Therapy Market – Revenue and Forecast to 2028 (USD Million)
11.3.7.6.2 Rest of Asia Pacific: Stem Cell Therapy Market, by Type, 2019-2028 (USD Million)
11.3.7.6.2.1 Rest of Asia Pacific: Stem Cell Therapy Market, by Adult Stem Cell Therapy, 2019-2028 (USD Million)
11.3.7.6.3 Rest of Asia Pacific: Stem Cell Therapy Market, by Treatment, 2019-2028 (USD Million)
11.3.7.6.4 Rest of Asia Pacific: Stem Cell Therapy Market, by Application, 2019-2028 (USD Million)
11.3.7.6.5 Rest of Asia Pacific: Stem Cell Therapy Market, by End User , 2019-2028 (USD Million)
11.4 Middle East & Africa: Stem Cell Therapy Market
11.4.1 Overview
11.4.2 Middle East & Africa: Stem Cell Therapy Market – Revenue and Forecast to 2028 (USD Million)
11.4.3 Middle East & Africa: Stem Cell Therapy Market, by Type, 2019-2028 (USD Million)
11.4.3.1 Middle East & Africa: Stem Cell Therapy Market, by Adult Stem Cell Therapy, 2019-2028 (USD Million)
11.4.4 Middle East & Africa: Stem Cell Therapy Market, by Treatment, 2019-2028 (USD Million)
11.4.5 Middle East & Africa: Stem Cell Therapy Market, by Application, 2019-2028 (USD Million)
11.4.6 Middle East & Africa: Stem Cell Therapy Market, by End User , 2019-2028 (USD Million)
11.4.7 Middle East & Africa: Stem Cell Therapy Market Share by Country – 2021 & 2028, (%)
11.4.7.1 Saudi Arabia: Stem Cell Therapy Market – Revenue and Forecast to 2028 (USD Million)
11.4.7.1.1 Saudi Arabia: Stem Cell Therapy Market – Revenue and Forecast to 2028 (USD Million)
11.4.7.1.2 Saudi Arabia: Stem Cell Therapy Market, by Type, 2019-2028 (USD Million)
11.4.7.1.2.1 Saudi Arabia: Stem Cell Therapy Market, by Adult Stem Cell Therapy, 2019-2028 (USD Million)
11.4.7.1.3 Saudi Arabia: Stem Cell Therapy Market, by Treatment, 2019-2028 (USD Million)
11.4.7.1.4 Saudi Arabia: Stem Cell Therapy Market, by Application, 2019-2028 (USD Million)
11.4.7.1.5 Saudi Arabia: Stem Cell Therapy Market, by End User , 2019-2028 (USD Million)
11.4.7.2 UAE: Stem Cell Therapy Market – Revenue and Forecast to 2028 (USD Million)
11.4.7.2.1 UAE: Stem Cell Therapy Market – Revenue and Forecast to 2028 (USD Million)
11.4.7.2.2 UAE: Stem Cell Therapy Market, by Type, 2019-2028 (USD Million)
11.4.7.2.2.1 UAE: Stem Cell Therapy Market, by Adult Stem Cell Therapy, 2019-2028 (USD Million)
11.4.7.2.3 UAE: Stem Cell Therapy Market, by Treatment, 2019-2028 (USD Million)
11.4.7.2.4 UAE: Stem Cell Therapy Market, by Application, 2019-2028 (USD Million)
11.4.7.2.5 UAE: Stem Cell Therapy Market, by End User , 2019-2028 (USD Million)
11.4.7.3 South Africa: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
11.4.7.3.1 South Africa: Stem Cell Therapy Market – Revenue and Forecast to 2028 (USD Million)
11.4.7.3.2 South Africa: Stem Cell Therapy Market, by Type, 2019-2028 (USD Million)
11.4.7.3.2.1 South Africa: Stem Cell Therapy Market, by Adult Stem Cell Therapy, 2019-2028 (USD Million)
11.4.7.3.3 South Africa: Stem Cell Therapy Market, by Treatment, 2019-2028 (USD Million)
11.4.7.3.4 South Africa: Stem Cell Therapy Market, by Application, 2019-2028 (USD Million)
11.4.7.3.5 South Africa: Stem Cell Therapy Market, by End User , 2019-2028 (USD Million)
11.4.7.4 Rest of Middle East and Africa: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
11.4.7.4.1 Rest of Middle East and Africa: Stem Cell Therapy Market – Revenue and Forecast to 2028 (USD Million)
11.4.7.4.2 Rest of Middle East and Africa: Stem Cell Therapy Market, by Type, 2019-2028 (USD Million)
11.4.7.4.2.1 Rest of Middle East and Africa: Stem Cell Therapy Market, by Adult Stem Cell Therapy, 2019-2028 (USD Million)
11.4.7.4.3 Rest of Middle East and Africa: Stem Cell Therapy Market, by Treatment, 2019-2028 (USD Million)
11.4.7.4.4 Rest of Middle East and Africa: Stem Cell Therapy Market, by Application, 2019-2028 (USD Million)
11.4.7.4.5 Rest of Middle East and Africa: Stem Cell Therapy Market, by End User , 2019-2028 (USD Million)
11.5 South and Central America: Stem Cell Therapy Market
11.5.1 Overview
11.5.2 South and Central America: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
11.5.3 South and Central America: Stem Cell Therapy Market, by Type, 2019-2028 (USD Million)
11.5.3.1 South and Central America: Stem Cell Therapy Market, by Adult Stem Cell Therapy, 2019-2028 (USD Million)
11.5.4 South and Central America: Stem Cell Therapy Market, by Treatment, 2019-2028 (USD Million)
11.5.5 South and Central America: Stem Cell Therapy Market, by Application, 2019-2028 (USD Million)
11.5.6 South and Central America: Stem Cell Therapy Market, by End User , 2019-2028 (USD Million)
11.5.7 South and Central America: Stem Cell Therapy Market, by Country, 2021 & 2028(%)
11.5.7.1 Brazil: Stem Cell Therapy Market – Revenue and Forecast to 2028 (USD Million)
11.5.7.1.1 Brazil: Stem Cell Therapy Market – Revenue and Forecast to 2028 (USD Million)
11.5.7.1.2 Brazil: Stem Cell Therapy Market, by Type, 2019-2028 (USD Million)
11.5.7.1.2.1 Brazil: Stem Cell Therapy Market, by Adult Stem Cell Therapy, 2019-2028 (USD Million)
11.5.7.1.3 Brazil: Stem Cell Therapy Market, by Treatment, 2019-2028 (USD Million)
11.5.7.1.4 Brazil: Stem Cell Therapy Market, by Application, 2019-2028 (USD Million)
11.5.7.1.5 Brazil: Stem Cell Therapy Market, by End User , 2019-2028 (USD Million)
11.5.7.2 Argentina: Stem Cell Therapy Market – Revenue and Forecast to 2028 (USD Million)
11.5.7.2.1 Argentina: Stem Cell Therapy Market – Revenue and Forecast to 2028 (USD Million)
11.5.7.2.2 Argentina: Stem Cell Therapy Market, by Type, 2019-2028 (USD Million)
11.5.7.2.2.1 Argentina: Stem Cell Therapy Market, by Adult Stem Cell Therapy, 2019-2028 (USD Million)
11.5.7.2.3 Argentina: Stem Cell Therapy Market, by Treatment, 2019-2028 (USD Million)
11.5.7.2.4 Argentina: Stem Cell Therapy Market, by Application, 2019-2028 (USD Million)
11.5.7.2.5 Argentina: Stem Cell Therapy Market, by End User , 2019-2028 (USD Million)
11.5.7.3 Rest of South and Central America: Stem Cell Therapy Market – Revenue and Forecast to 2028 (USD Million)
11.5.7.3.1 Rest of South and Central America: Stem Cell Therapy Market – Revenue and Forecast to 2028 (USD Million)
11.5.7.3.2 Rest of South and Central America: Stem Cell Therapy Market, by Type, 2019-2028 (USD Million)
11.5.7.3.2.1 Rest of South and Central America: Stem Cell Therapy Market, by Adult Stem Cell Therapy, 2019-2028 (USD Million)
11.5.7.3.3 Rest of South and Central America: Stem Cell Therapy Market, by Treatment, 2019-2028 (USD Million)
11.5.7.3.4 Rest of South and Central America: Stem Cell Therapy Market, by Application, 2019-2028 (USD Million)
11.5.7.3.5 Rest of South and Central America: Stem Cell Therapy Market, by End User , 2019-2028 (USD Million)
12. Impact Of COVID-19 Pandemic on Stem Cell Therapy Market
12.1 North America: Impact Assessment of COVID-19 Pandemic
12.2 Europe: Impact Assessment of COVID-19 Pandemic
12.3 Asia Pacific: Impact Assessment of COVID-19 Pandemic
12.4 Middle East & Africa: Impact Assessment of COVID-19 Pandemic
12.5 South & Central America: Impact Assessment of COVID-19 Pandemic
13. Stem Cell Therapy Market–Industry Landscape
13.1 Overview
13.2 Growth Strategies in the Stem Cell Therapy Market (%)
13.3 Organic Developments
13.3.1 Overview
13.4 Inorganic Developments
13.4.1 Overview
14. Company Profiles
14.1 MEDIPOST
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 RichSource
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 BioTime, Inc.
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 Mesoblast Limited
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 Holostem Terapie Avanzate Srl
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 U.S. Stem Cell, Inc.
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 TiGenix NV
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 AlloSource
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 NuVasive Inc
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
14.10 JCR Pharmaceuticals Co. Ltd.
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments
15. Appendix
15.1 About The Insight Partners
15.2 Glossary of Terms
LIST OF TABLES
Table 1. North America Stem Cell Therapy Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 2. North America Stem Cell Therapy Market, by Adult Stem Cell Therapy – Revenue and Forecast to 2028 (US$ Million)
Table 3. North America Stem Cell Therapy Market, by Treatment – Revenue and Forecast to 2028 (US$ Million)
Table 4. North America Stem Cell Therapy Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 5. North America Stem Cell Therapy Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 6. US Stem Cell Therapy Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 7. US Stem Cell Therapy Market, by Adult Stem Cell Therapy – Revenue and Forecast to 2028 (US$ Million)
Table 8. US Stem Cell Therapy Market, by Treatment – Revenue and Forecast to 2028 (US$ Million)
Table 9. US Stem Cell Therapy Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 10. US Stem Cell Therapy Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 11. Canada Stem Cell Therapy Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 12. Canada Stem Cell Therapy Market, by Adult Stem Cell Therapy – Revenue and Forecast to 2028 (US$ Million)
Table 13. Canada Stem Cell Therapy Market, by Treatment – Revenue and Forecast to 2028 (US$ Million)
Table 14. Canada Stem Cell Therapy Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 15. Canada Stem Cell Therapy Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 16. Mexico Stem Cell Therapy Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 17. Mexico Stem Cell Therapy Market, by Adult Stem Cell Therapy – Revenue and Forecast to 2028 (US$ Million)
Table 18. Mexico Stem Cell Therapy Market, by Treatment – Revenue and Forecast to 2028 (US$ Million)
Table 19. Mexico Stem Cell Therapy Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 20. Mexico Stem Cell Therapy Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 21. Europe Stem Cell Therapy Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 22. Europe Stem Cell Therapy Market, by Adult Stem Cell Therapy – Revenue and Forecast to 2028 (US$ Million)
Table 23. Europe Stem Cell Therapy Market, by Treatment – Revenue and Forecast to 2028 (US$ Million)
Table 24. Europe Stem Cell Therapy Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 25. Europe Stem Cell Therapy Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 26. Germany Stem Cell Therapy Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 27. Germany Stem Cell Therapy Market, by Adult Stem Cell Therapy – Revenue and Forecast to 2028 (US$ Million)
Table 28. Germany Stem Cell Therapy Market, by Treatment – Revenue and Forecast to 2028 (US$ Million)
Table 29. Germany Stem Cell Therapy Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 30. Germany Stem Cell Therapy Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 31. UK Stem Cell Therapy Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 32. UK Stem Cell Therapy Market, by Adult Stem Cell Therapy – Revenue and Forecast to 2028 (US$ Million)
Table 33. UK Stem Cell Therapy Market, by Treatment – Revenue and Forecast to 2028 (US$ Million)
Table 34. UK Stem Cell Therapy Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 35. UK Stem Cell Therapy Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 36. France Stem Cell Therapy Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 37. France Stem Cell Therapy Market, by Adult Stem Cell Therapy – Revenue and Forecast to 2028 (US$ Million)
Table 38. France Stem Cell Therapy Market, by Treatment – Revenue and Forecast to 2028 (US$ Million)
Table 39. France Stem Cell Therapy Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 40. France Stem Cell Therapy Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 41. Italy Stem Cell Therapy Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 42. Italy Stem Cell Therapy Market, by Adult Stem Cell Therapy – Revenue and Forecast to 2028 (US$ Million)
Table 43. Italy Stem Cell Therapy Market, by Treatment – Revenue and Forecast to 2028 (US$ Million)
Table 44. Italy Stem Cell Therapy Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 45. Italy Stem Cell Therapy Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 46. Spain Stem Cell Therapy Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 47. Spain Stem Cell Therapy Market, by Adult Stem Cell Therapy – Revenue and Forecast to 2028 (US$ Million)
Table 48. Spain Stem Cell Therapy Market, by Treatment – Revenue and Forecast to 2028 (US$ Million)
Table 49. Spain Stem Cell Therapy Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 50. Spain Stem Cell Therapy Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 51. Rest of Europe Stem Cell Therapy Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 52. Rest of Europe Stem Cell Therapy Market, by Adult Stem Cell Therapy – Revenue and Forecast to 2028 (US$ Million)
Table 53. Rest of Europe Stem Cell Therapy Market, by Treatment – Revenue and Forecast to 2028 (US$ Million)
Table 54. Rest of Europe Stem Cell Therapy Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 55. Rest of Europe Stem Cell Therapy Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 56. Asia Pacific Stem Cell Therapy Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 57. Asia Pacific Stem Cell Therapy Market, by Adult Stem Cell Therapy – Revenue and Forecast to 2028 (USD Million)
Table 58. Asia Pacific Stem Cell Therapy Market, by Treatment – Revenue and Forecast to 2028 (USD Million)
Table 59. Asia Pacific Stem Cell Therapy Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 60. Asia Pacific Stem Cell Therapy Market, by End-User – Revenue and Forecast to 2028 (USD Million)
Table 61. China Stem Cell Therapy Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 62. China Stem Cell Therapy Market, by Adult Stem Cell Therapy – Revenue and Forecast to 2028 (USD Million)
Table 63. China Stem Cell Therapy Market, by Treatment – Revenue and Forecast to 2028 (USD Million)
Table 64. China Stem Cell Therapy Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 65. China Stem Cell Therapy Market, by End-User – Revenue and Forecast to 2028 (USD Million)
Table 66. Japan Stem Cell Therapy Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 67. Japan Stem Cell Therapy Market, by Adult Stem Cell Therapy – Revenue and Forecast to 2028 (USD Million)
Table 68. Japan Stem Cell Therapy Market, by Treatment – Revenue and Forecast to 2028 (USD Million)
Table 69. Japan Stem Cell Therapy Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 70. Japan Stem Cell Therapy Market, by End-User – Revenue and Forecast to 2028 (USD Million)
Table 71. India Stem Cell Therapy Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 72. India Stem Cell Therapy Market, by Adult Stem Cell Therapy – Revenue and Forecast to 2028 (USD Million)
Table 73. India Stem Cell Therapy Market, by Treatment – Revenue and Forecast to 2028 (USD Million)
Table 74. India Stem Cell Therapy Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 75. India Stem Cell Therapy Market, by End-User – Revenue and Forecast to 2028 (USD Million)
Table 76. South Korea Stem Cell Therapy Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 77. South Korea Stem Cell Therapy Market, by Adult Stem Cell Therapy – Revenue and Forecast to 2028 (USD Million)
Table 78. South Korea Stem Cell Therapy Market, by Treatment – Revenue and Forecast to 2028 (USD Million)
Table 79. South Korea Stem Cell Therapy Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 80. South Korea Stem Cell Therapy Market, by End-User – Revenue and Forecast to 2028 (USD Million)
Table 81. Australia Stem Cell Therapy Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 82. Australia Stem Cell Therapy Market, by Adult Stem Cell Therapy – Revenue and Forecast to 2028 (USD Million)
Table 83. Australia Stem Cell Therapy Market, by Treatment – Revenue and Forecast to 2028 (USD Million)
Table 84. Australia Stem Cell Therapy Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 85. Australia Stem Cell Therapy Market, by End-User – Revenue and Forecast to 2028 (USD Million)
Table 86. Rest of Asia Pacific Stem Cell Therapy Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 87. Rest of Asia Pacific Stem Cell Therapy Market, by Adult Stem Cell Therapy – Revenue and Forecast to 2028 (USD Million)
Table 88. Rest of Asia Pacific Stem Cell Therapy Market, by Treatment – Revenue and Forecast to 2028 (USD Million)
Table 89. Rest of Asia Pacific Stem Cell Therapy Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 90. Rest of Asia Pacific Stem Cell Therapy Market, by End-User – Revenue and Forecast to 2028 (USD Million)
Table 91. Middle East & Africa Stem Cell Therapy Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 92. Middle East & Africa Stem Cell Therapy Market, by Adult Stem Cell Therapy – Revenue and Forecast to 2028 (USD Million)
Table 93. Middle East & Africa Stem Cell Therapy Market, by Treatment – Revenue and Forecast to 2028 (USD Million)
Table 94. Middle East & Africa Stem Cell Therapy Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 95. Middle East & Africa Stem Cell Therapy Market, by End-User – Revenue and Forecast to 2028 (USD Million)
Table 96. Saudi Arabia Stem Cell Therapy Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 97. Saudi Arabia Stem Cell Therapy Market, by Adult Stem Cell Therapy – Revenue and Forecast to 2028 (USD Million)
Table 98. Saudi Arabia Stem Cell Therapy Market, by Treatment – Revenue and Forecast to 2028 (USD Million)
Table 99. Saudi Arabia Stem Cell Therapy Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 100. Saudi Arabia Stem Cell Therapy Market, by End-User – Revenue and Forecast to 2028 (USD Million)
Table 101. UAE Stem Cell Therapy Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 102. UAE Stem Cell Therapy Market, by Adult Stem Cell Therapy – Revenue and Forecast to 2028 (USD Million)
Table 103. UAE Stem Cell Therapy Market, by Treatment – Revenue and Forecast to 2028 (USD Million)
Table 104. UAE Stem Cell Therapy Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 105. UAE Stem Cell Therapy Market, by End-User – Revenue and Forecast to 2028 (USD Million)
Table 106. South Africa Stem Cell Therapy Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 107. South Africa Stem Cell Therapy Market, by Adult Stem Cell Therapy – Revenue and Forecast to 2028 (USD Million)
Table 108. South Africa Stem Cell Therapy Market, by Treatment – Revenue and Forecast to 2028 (USD Million)
Table 109. South Africa Stem Cell Therapy Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 110. South Africa Stem Cell Therapy Market, by End-User – Revenue and Forecast to 2028 (USD Million)
Table 111. Rest of Middle East and Africa Stem Cell Therapy Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 112. Rest of Middle East and Africa Stem Cell Therapy Market, by Adult Stem Cell Therapy – Revenue and Forecast to 2028 (USD Million)
Table 113. Rest of Middle East and Africa Stem Cell Therapy Market, by Treatment – Revenue and Forecast to 2028 (USD Million)
Table 114. Rest of Middle East and Africa Stem Cell Therapy Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 115. Rest of Middle East and Africa Stem Cell Therapy Market, by End-User – Revenue and Forecast to 2028 (USD Million)
Table 116. South and Central America Stem Cell Therapy Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 117. South and Central America Stem Cell Therapy Market, by Adult Stem Cell Therapy – Revenue and Forecast to 2028 (USD Million)
Table 118. South and Central America Stem Cell Therapy Market, by Treatment – Revenue and Forecast to 2028 (USD Million)
Table 119. South and Central America Stem Cell Therapy Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 120. South and Central America Stem Cell Therapy Market, by End-User – Revenue and Forecast to 2028 (USD Million)
Table 121. Brazil Stem Cell Therapy Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 122. Brazil Stem Cell Therapy Market, by Adult Stem Cell Therapy – Revenue and Forecast to 2028 (USD Million)
Table 123. Brazil Stem Cell Therapy Market, by Treatment – Revenue and Forecast to 2028 (USD Million)
Table 124. Brazil Stem Cell Therapy Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 125. Brazil Stem Cell Therapy Market, by End-User – Revenue and Forecast to 2028 (USD Million)
Table 126. Argentina Stem Cell Therapy Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 127. Argentina Stem Cell Therapy Market, by Adult Stem Cell Therapy – Revenue and Forecast to 2028 (USD Million)
Table 128. Argentina Stem Cell Therapy Market, by Treatment – Revenue and Forecast to 2028 (USD Million)
Table 129. Argentina Stem Cell Therapy Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 130. Argentina Stem Cell Therapy Market, by End-User – Revenue and Forecast to 2028 (USD Million)
Table 131. Rest of South and Central America Stem Cell Therapy Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 132. Rest of South and Central America Stem Cell Therapy Market, by Adult Stem Cell Therapy – Revenue and Forecast to 2028 (USD Million)
Table 133. Rest of South and Central America Stem Cell Therapy Market, by Treatment – Revenue and Forecast to 2028 (USD Million)
Table 134. Rest of South and Central America Stem Cell Therapy Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 135. Rest of South and Central America Stem Cell Therapy Market, by End-User – Revenue and Forecast to 2028 (USD Million)
Table 136. Organic Developments in the Stem Cell Therapy Market
Table 137. Inorganic Developments in the Stem Cell Therapy Market
Table 138. Glossary of Terms
LIST OF FIGURES
Figure 1. Stem Cell Therapy Market Segmentation
Figure 2. Stem Cell Therapy Segmentation, By Region
Figure 3. Global Stem Cell Therapy Market Overview
Figure 4. Adult Stem Cell Therapy Segment Held Largest Share of Type Segment in Stem Cell Therapy Market
Figure 5. Asia-Pacific Region Is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. Global Stem Cell Therapy Market, By Geography (US$ Million)
Figure 7. Global Stem Cell Therapy Market- Leading Country Markets (US$ Million)
Figure 8. Global Stem Cell Therapy Market – Industry Landscape
Figure 9. North America: PEST Analysis
Figure 10. Europe PEST Analysis
Figure 11. Asia Pacific PEST Analysis
Figure 12. South and Central America (SCAM) PEST Analysis
Figure 13. Middle East and Africa: PEST Analysis
Figure 14. Experts Opinion
Figure 15. Stem Cell Therapy Market Impact Analysis of Drivers and Restraints
Figure 16. Global Stem Cell Therapy Market – Revenue Forecast and Analysis – 2020- 2028
Figure 17. Global Stem Cell Therapy Market – By Geography Forecast and Analysis – 2021- 2028
Figure 18. Market Positioning of Key Players In Global Stem Cell Therapy Market
Figure 19. Stem Cell Therapy Market Revenue Share, by Type 2021 & 2028 (%)
Figure 20. Adult Stem Cell Therapy: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. Hematopoietic Stem Cell Therapy: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. Umbilical Cord Stem Cell Therapy: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23. Neuronal Stem Cell Therapy: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 24. Mesenchymal Stem Cell: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 25. Embryonic Stem Cell Therapy: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 26. Induced Pluripotent Stem Cell Therapy: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 27. Other Stem Cell Therapy: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 28. Global Stem Cell Therapy Market, by Treatment 2021 & 2028 (%)
Figure 29. Allogeneic: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 30. Autologous: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 31. Global Stem Cell Therapy Market, by Application 2021 & 2028 (%)
Figure 32. Musculoskeletal: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 33. Dermatology: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 34. Cardiology: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 35. Drug Discovery and Development: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 36. Other Applications: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 37. Stem Cell Therapy Market Revenue Share, by End User 2021 & 2028 (%)
Figure 38. Academic & Research Institutes: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 39. Hospitals & Specialty Clinics: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 40. North America: Stem Cell Therapy Market, by Key Country – Revenue (2021) (US$ Million)
Figure 41. North America Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 42. North America: Stem Cell Therapy Market, by Country, 2021 & 2028 (%)
Figure 43. US: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 44. Canada: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 45. Mexico: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 46. Europe: Stem Cell Therapy Market, by Key Country – Revenue (2021) (US$ Million)
Figure 47. Europe Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 48. Europe: Stem Cell Therapy Market, by Country, 2021 & 2028 (%)
Figure 49. Germany: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 50. UK: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 51. France: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 52. Italy: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 53. Spain: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 54. Rest of Europe: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 55. Asia Pacific: Stem Cell Therapy Market, by Key Country – Revenue (2021) (USD Million)
Figure 56. Asia Pacific Stem Cell Therapy Market Revenue and Forecast to 2028 (USD Million)
Figure 57. China: Stem Cell Therapy Market – Revenue and Forecast to 2028 (USD Million)
Figure 58. Japan: Stem Cell Therapy Market – Revenue and Forecast to 2028 (USD Million)
Figure 59. India: Stem Cell Therapy Market – Revenue and Forecast to 2028 (USD Million)
Figure 60. South Korea: Stem Cell Therapy Market – Revenue and Forecast to 2028 (USD Million)
Figure 61. Australia: Stem Cell Therapy Market – Revenue and Forecast to 2028 (USD Million)
Figure 62. Rest of Asia Pacific: Stem Cell Therapy Market – Revenue and Forecast to 2028 (USD Million)
Figure 63. Middle East & Africa: Stem Cell Therapy Market, by Key Country – Revenue (2021) (USD Million)
Figure 64. Middle East & Africa Stem Cell Therapy Market Revenue and Forecast to 2028 (USD Million)
Figure 65. Middle East & Africa: Stem Cell Therapy Market Share by Country – 2021 & 2028, (%)
Figure 66. Saudi Arabia: Stem Cell Therapy Market – Revenue and Forecast to 2028 (USD Million)
Figure 67. UAE: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 68. South Africa: Stem Cell Therapy Market – Revenue and Forecast to 2028 (USD Million)
Figure 69. Rest of Middle East and Africa: Stem Cell Therapy Market – Revenue and Forecast to 2028 (USD Million)
Figure 70. South and Central America: Stem Cell Therapy Market, by Key Country – Revenue (2021) (USD Million)
Figure 71. South and Central America Stem Cell Therapy Market Revenue and Forecast to 2028 (USD Million)
Figure 72. South and Central America: Stem Cell Therapy Market, by Country, 2021 & 2028 (%)
Figure 73. Brazil: Stem Cell Therapy Market – Revenue and Forecast to 2028 (USD Million)
Figure 74. Argentina: Stem Cell Therapy Market – Revenue and Forecast to 2028 (USD Million)
Figure 75. Rest of South and Central America: Stem Cell Therapy Market – Revenue and Forecast to 2028 (USD Million)
Figure 76. Impact of COVID-19 Pandemic on North American Country Markets
Figure 77. Impact of COVID-19 Pandemic in European Country Markets
Figure 78. Impact of COVID-19 Pandemic in Asia Pacific Country Markets
Figure 79. Impact of COVID-19 Pandemic in Middle East & Africa Country Markets
Figure 80. Impact of COVID-19 Pandemic in South & Central America Country Markets
Figure 81. Growth Strategies in the Stem Cell Therapy Market (%)
• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the stem cell therapy market.
• Highlights key business priorities in order to assist companies to realign their business strategies.
• The key findings and recommendations highlight crucial progressive industry trends in the global stem cell therapy market, thereby allowing players across the value chain to develop effective long-term strategies.
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
• Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
• Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
The List of Companies – Stem Cell Therapy Market
• MEDIPOST
• RichSource
• BioTime, Inc.
• Mesoblast Limited
• Holostem Terapie Avanzate Srl
• U.S. Stem Cell, Inc.
• TiGenix NV
• AlloSource
• NuVasive Inc
• JCR Pharmaceuticals Co. Ltd.
Growing Prevalence of Cancer Fuels Stem Cell Therapy Market Growth
According to our new research study on “Stem Cell Therapy Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Type, Treatment, Application, and End User,” the stem cell therapy market size is expected to reach US$ 6,206.89 million by 2028 from US$ 2,278.49 million in 2022, with an estimated CAGR of 18.2%. The report highlights trends prevailing in the market, and drivers and restraints pertaining to the stem cell therapy market growth.
Cancer is one of the leading causes of mortality across the world, and the disease is profoundly affecting the quality of life. According to estimates published by the American Cancer Society in 2023, the US had at least 42% of newly diagnosed cancer cases, accounting for 805,600 cases in 2022, excluding non-melanoma skin cancer. Similarly, the treatment of cancer accounts for a high percentage of healthcare expenditure in the US alone. According to the National Cancer Institutes, the cancer-related direct medical cost in the US is projected to grow from US$ 183 billion in 2015 to US$ 246 billion by 2030, registering a 34% increase. This can be attributed to the rising geriatric population, and surging prevalence of smoking, obesity, and physical inactivity. The National Cancer Institute report also states that stem cell transplants assist in the restoration of blood-forming cells among cancer patients undergoing chemotherapy or radiation therapy. Blood-forming stem cells are important as they facilitate the growth of different types of blood cells, such as white blood cells (WBCs), red blood cells (RBCs), and platelets. Stem cell transplants do not function directly against cancer; instead, they help recover the body’s ability to produce stem cells after treatment with high doses of radiation therapy, chemotherapy, or both. Thus, an increase in the demand for advanced cancer treatment is driving the growth of the stem cell therapy market.
North America held the largest share of the stem cell therapy market in 2021. The prominent market share of the region is attributed to the growing awareness regarding the use of stem cells in disease treatment, favorable reimbursement policies for stem cell therapy research & development activities, increasing emphasis on stem cell banking, and the presence of major market players. In North America, the US is the largest market for stem cell therapy. The growing emphasis on lowering hospitalizations and healthcare costs primarily drives the stem cell therapy market growth in the US. Increasing financial aid by investors, government authorities, and significant players also supports the stem cell therapy market growth in the US. For instance, in July 2019, Century Therapeutics raised US$ 250 Million through a financing round to develop induced pluripotent stem cells (iPSC) to utilize them in allogeneic cell therapy.. Moreover, developments in regenerative medicines are expected to drive the acceptance and adoption of stem cell therapy in the US. In May 2019, SpinalCyte, LLC, a clinical-stage regenerative medicine company, announced the launch of a new comprehensive platform to raise awareness of the potential benefits served by fibroblasts and their promising applications in regenerative medicine technology. Thus, the increasing application of regenerative medicines in disease management, and surging financial aid by investors, government authorities, and significant players boost the stem cell therapy market growth in North America.
The COVID-19 pandemic had a positive impact on the stem cell therapy market. The application of stem cells in the treatment of COVID-19 infection has gathered the attention of medical researchers, resulting in a higher number of clinical trials. Regenerative medicine based on cellular therapies may be developed as a treatment option for patients, lowering infection rates and mortality. Research institutes and companies are collaborating to develop novel treatment options for COVID-19. For instance, in April 2020, Infectious Disease Research Institute and Celularity announced that the US FDA had approved a clinical trial application to develop cell-based therapy for COVID-19. Thus, researchers are increasingly attempting to develop stem cell therapies targeting COVID-19. In January 2020, researchers from the University of Miami administered two stem cell infusions to COVID-19 patients suffering from lung damage. The results concluded that there were no significant side effects, and the therapy was reliable. Thus, increasing demand for regenerative medicines has had a positive effect on the stem cell therapy market during the COVID-19 pandemic.
Medipost; NuVasive Inc.; JCR Pharmaceuticals Co. Ltd.; AlloSource; Holostem Terapie Avanzate S.R.L.; Mesoblast Ltd.; U.S. Stem Cell, Inc.; Biotime, Inc.; RichSource; Caladrius; and TiGenix NV (Takeda Pharmaceuticals) are among the leading companies operating in the global stem cell therapy market.
The global stem cell therapy market is segmented on the basis of type, treatment, application, end user, and geography. Based on type, the market is segmented into adult stem cell therapy, induced pluripotent stem cell therapy, embryonic stem cell therapy, and other stem cell therapy. By treatment, the stem cell therapy market is bifurcated into allogeneic and autologous. In terms of application, the stem cell therapy market is segmented into musculoskeletal, dermatology, cardiology, drug discovery and development, and other applications. Based on end user, the market is segmented into academic & research institutes and hospitals & clinics. In terms of geography, the stem cell therapy market is segmented into North America (US, Canada, and Mexico), Europe (UK, Germany, France, Italy, Spain, and Rest of Europe), Asia Pacific (China, Japan, India, Australia, South Korea, and Rest of Asia Pacific), the Middle East & Africa (UAE, Saudi Arabia, Africa, and Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and Rest of South & Central America).
Related Reports
- $3,000.00 – $5,000.00
